Spots Global Cancer Trial Database for Clinical and Basic Study for Pediatric Liver Transplantation

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Clinical and Basic Study for Pediatric Liver Transplantation

Official Title: Clinical and Basic Study for Pediatric Liver Transplantation

Study ID: NCT02503384

Conditions

Biliary Atresia

Metabolic Disorders

Fulminant Liver Failure

Hepatic Tumors

Interventions

Study Description

Brief Summary: Background: In mainland China, the development of pediatric liver transplantation (LT) has lagged behind that of adult LT during the past two decades, but it has been progressing immensely in recent years. Renji hospital(shanghai) is currently the largest pediatric transplant center in mainland China. Aim and method: This study is performed for establishment of key techniques for pediatric LT in mainland China, including the indications and timing for pediatric LT, the criteria for donor selections, living donor LT planning, prevention and treatment for posttransplant complications, long-term follow-up management et al.

Detailed Description: Outcome measures: * Annual caseloads of pediatric liver transplantation * Patient survival: 1-, 3- and 5-year patient survival after liver transplantation * Graft survival: 1-, 3- and 5-year graft survival after liver transplantation * Posttransplant complications, such as biliary complications, vascular complications, acute rejections, infections et al. * Perioperative data, such as duration of operations, postoperative hospital stay et al. * Clinical data for living donors.